Skip to main content
TipRanks
Go Ultimate75% OFF

AIM ImmunoTech (HXB) Stock Forecast & Price Target

1 Followers
See the Price Targets and Ratings of:

HXB Analyst Ratings

Moderate Buy
1Ratings
1Buy0Hold0Sell
Based on 1 analysts giving stock ratings to AIM ImmunoTech in the past 3 months

HXB Stock 12 Month Forecast

€6.35▲(4.22% Upside)
Based on 1 Wall Street analysts offering 12 month price targets for AIM ImmunoTech in the last 3 months. The average price target is EUR 6.35 with a high forecast of EUR 6.35 and a low forecast of EUR 6.35. The average price target represents a 4.22% change from the last price of EUR 6.09.
Highest Price Target€6.35Average Price Target€6.35Lowest Price Target€6.35

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for DE:HXB
Price TargetArticle
Ascendiant€8.16→€6.35buy4.22%UpsideReiterated08/19/26
Maxim Group€1.36buy-77.67%DownsideReiterated08/12/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
QUITAchieve Life Sciences
SLDBSolid Biosciences
RDNTRadnet
PTGXProtagonist Therapeutics
HROWHarrow Health

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering AIM ImmunoTech

3 Months
Edward Woo
Edward WooAscendiant
Success Rate3/11 ratings generated profit
27%
Average Return
-7.99%

Copying Edward Woo's trades and holding each position for 3 Months would result in 27.27% of your transactions generating a profit, with an average return of -7.99% per trade.

1 Year
Edward Woo
Edward WooAscendiant
Success Rate1/11 ratings generated profit
9%
Average Return
-63.72%

Copying Edward Woo's trades and holding each position for 1 Year would result in 9.09% of your transactions generating a profit, with an average return of -63.72% per trade.

2 Years
Edward Woo
Edward WooAscendiant
Success Rate0/11 ratings generated profit
0%
Average Return
-80.41%

Copying Edward Woo's trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -80.41% per trade.

HXB Analyst Recommendation Trends

02468Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26
Monthly rating counts for HXB
RatingJul 26Aug 26Sep 26Oct 26Nov 26
Strong Buy43220
Buy00000
Hold00000
Sell00000
Strong Sell00000
total43220

In the current month, HXB has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. HXB average Analyst price target in the past 3 months is 6.35.

HXB Financial Forecast

€-5€-3.75€-2.5€-1.25€0Q3 2025Q2 2026Q2 2027
Consensus€-0.39

HXB Earnings Forecast

Next quarter’s earnings estimate for HXB is -EUR 0.39 with a range of ― to ―. The previous quarter’s EPS was -EUR 0.39. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.

€19,958€20,865.8€21,773.5€22,681.3€23,589Q3 2025Q2 2026Q2 2027
Consensus€23.6K

HXB Sales Forecast

Next quarter’s sales forecast for HXB is EUR 23.59K with a range of ― to ―. The previous quarter’s sales results were EUR 23.59K. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

HXB Stock Forecast FAQ

What is DE:HXB’s average 12-month price target, according to analysts?
Based on analyst ratings, AIM ImmunoTech’s 12-month average price target is €6.35.
What is DE:HXB’s upside potential, based on the analysts’ average price target?
AIM ImmunoTech has 4.22% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is AIM ImmunoTech a Buy, Sell or Hold?
AIM ImmunoTech has a consensus rating of Moderate Buy, which is based on 1 buy ratings, 0 hold ratings and 0 sell ratings.
What is AIM ImmunoTech’s share price target?
The average share price target for AIM ImmunoTech is €6.35. This is based on 1 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is €6.35, and the lowest forecast is €6.35. The average share price target represents a 4.22% increase from the current price of €6.093.
What do analysts say about AIM ImmunoTech?
AIM ImmunoTech’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 1 Wall Street analysts.
How can I buy shares of AIM ImmunoTech?
To buy shares of DE:HXB, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.